EXICURE, INC. Contract with Customer, Liability, Noncurrent
EXICURE, INC. (XCUR) had Contract with Customer, Liability, Noncurrent of $0 as of 2022-12-31, per its 10-K filed 2023-03-27.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent › Deferred Revenue, Noncurrent
us-gaap:ContractWithCustomerLiabilityNoncurrent · last filed 2023-03-27
- 2022-12-31: Contract with Customer, Liability, Noncurrent $0.00.
- 2022-09-30: Contract with Customer, Liability, Noncurrent $0.00.
- 2022-06-30: Contract with Customer, Liability, Noncurrent $9.04M.
- 2022-03-31: Contract with Customer, Liability, Noncurrent $10.04M.
| Period end | Contract with Customer, Liability, Noncurrent |
|---|---|
| 2022-12-31 | $0.00 10-K · filed 2023-03-27 |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-14 |
| 2022-06-30 | $9.04M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $10.04M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $11.51M 10-K · filed 2023-03-27 |
| 2021-09-30 | $16.93M 10-Q · filed 2021-11-19 |
| 2020-12-31 | $0.00 10-K · filed 2022-03-25 |
| 2020-09-30 | $0.00 10-Q · filed 2020-11-12 |
| 2020-06-30 | $0.00 10-Q · filed 2020-08-12 |
| 2020-03-31 | $0.00 10-Q · filed 2020-05-14 |
| 2019-12-31 | $2.96M 10-K · filed 2021-03-11 |
| 2018-12-31 | $0.00 10-K · filed 2020-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |